Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0E6LC
|
||||
Former ID |
DNC001363
|
||||
Drug Name |
SPR-210
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetic complication [ICD10:E08-E13] | Terminated | [545343] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H11F3N2O3S2
|
||||
Canonical SMILES |
CC1=C2C(=CC=C1)SC(C(=O)N2C3=NC4=C(C(=CC(=C4S3)F)F)F)CC(<br />=O)O
|
||||
InChI |
1S/C18H11F3N2O3S2/c1-7-3-2-4-10-15(7)23(17(26)11(27-10)6-12(24)25)18-22-14-13(21)8(19)5-9(20)16(14)28-18/h2-5,11H,6H2,1H3,(H,24,25)
|
||||
InChIKey |
ZVSDXQXCVBUOHA-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 143162-65-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [537904] | |
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.